Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CMP stock price vs TECH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TECH's multiple
Needs Annual EPS, TECH P/E.
Implied fair value · at CMP's multiple
Needs CMP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Compass Minerals International, Inc. · implied price per share
Bear
-$7.09
Base
-$5.01
Bull
-$2.31
BIO-TECHNE Corp · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MOSAIC CO
CMP vs MOS
Intrepid Potash, Inc.
CMP vs IPI
MARTIN MARIETTA MATERIALS INC
CMP vs MLM
Vulcan Materials CO
CMP vs VMC
HECLA MINING CO/DE/
CMP vs HL
THERMO FISHER SCIENTIFIC INC.
CMP vs TMO
DANAHER CORP /DE/
CMP vs DHR
AGILENT TECHNOLOGIES, INC.
CMP vs A
WATERS CORP /DE/
CMP vs WAT
ILLUMINA, INC.
CMP vs ILMN
BRUKER CORP
CMP vs BRKR
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CMP can sustain revenue growth while materially improving margins and reducing leverage, then the stock may be worth holding or accumulating because the current price is far below TECH-implied valuation; otherwise, the weak profitability and 11.4x net debt/EBITDA argue against paying up for TECH multiple.
On a P/S basis, CMP trades at 1.0x versus TECH at 9.1x, which is the primary driver of the very large implied upside to $270.46 from a current price of $29.95. However, that comparison is stretched by the fact that TECH is a much higher-quality business on margins and leverage, while CMP’s own DCF range of $1.32 to $1.79 suggests the market is already discounting significant fundamental weakness.
Supporting Metrics
